| abstract |
The present invention relates to the compound (2R, 2'R) -bis ((((((tetrahydro-2H-pyran-4-yl) oxy) carbonyl) oxy) methyl) -1,1'-adipoylbis (pyrrolidine-2-carboxylate ), the pharmaceutical compositions containing this compound and the use of this compound for the treatment of diseases or disorders where the depletion of serum amyloid P component (SAP) may be beneficial, including amyloidosis, Alzheimer's disease, type 2 diabetes and osteoarthritis. |